Prenatal phthalate exposure, oxidative stress-related genetic vulnerability and early life neurodevelopment: A birth

Anne-Louise Ponsonby1, Christos Symeonides2, Richard Saffery2

  • 1The Florey Institute for Neuroscience and Mental Health, Australia; Murdoch Children's Research Institute, Royal Children's Hospital Melbourne, University of Melbourne, Victoria, Australia.

Neurotoxicology
|June 2, 2020
PubMed

Insights

Prenatal exposure to phthalates and genetic vulnerability to oxidative stress are linked to adverse child neurodevelopment, including autism spectrum disorder (ASD). Combined exposures amplify risks, suggesting a need to re-evaluate current maternal phthalate exposure guidelines.

Area of Science:

  • Environmental Health
  • Neurodevelopmental Pediatrics
  • Toxicology

Background:

  • Prenatal phthalate exposure is a potential neurodevelopmental risk factor, but findings are inconsistent.
  • Oxidative stress mechanisms may mediate phthalate-induced neurodevelopmental effects.
  • Genetic predisposition to oxidative stress could modify phthalate impacts.

Purpose of the Study:

  • To examine the interaction between maternal prenatal phthalate levels and infant genetic susceptibility to oxidative stress on child neurodevelopment.
  • To investigate the combined effects of prenatal phthalates and other oxidative stress factors on neurodevelopmental outcomes.
  • To assess associations with autism spectrum disorder (ASD), ASD traits, cognition, and inattention/hyperactivity.

Main Methods:

  • A population-based birth cohort of 1064 pregnant women in Australia.
  • Maternal urine phthalate metabolite measurement at 36 weeks gestation.
  • Candidate gene approach to create an oxidative stress genetic score; neurodevelopmental assessments (e.g., BAYLEY-III, ASD questionnaires) at age two.

Main Results:

  • Higher prenatal phthalate levels and higher oxidative stress genetic scores were independently associated with increased risk of ASD.
  • Specific single nucleotide polymorphisms (SNPs) related to oxidative stress modified the phthalate-ADHD association.
  • Consistent patterns of adverse effects were observed for cognition, ASD, ASD traits, and inattention/hyperactivity when combining genetic vulnerability and phthalate exposure.

Conclusions:

  • Prenatal phthalate exposure and infant genetic vulnerability to oxidative stress are associated with adverse neurodevelopmental outcomes.
  • Combined exposures to phthalates and other oxidative stressors (e.g., smoking) increase neurodevelopmental risks.
  • Current recommendations and regulations regarding maternal phthalate exposure during pregnancy warrant re-evaluation.